San Diego, CA – July 9, 2015 – Pathway Genomics Corporation, a global precision medicine company with mobile solutions for clinical laboratory testing to empower physicians and their patients to take control of their health and wellness, announced today that Paul Sonnier, digital health advocate and social entrepreneur, is joining the company’s Strategic Advisory Board.
Click to Tweet

Former United States Secretary of Commerce Barbara Franklin Joins Pathway Genomics’ Board of DirectorsSan Diego, CA – June 16, 2015 – Pathway Genomics Corporation, a global precision medicine company with mobile health solutions for clinical laboratory testing to empower physicians and their patients to take control of their health and wellness, announced today that the 29th U.S. Secretary of Commerce, The Honorable Barbara Franklin is joining the company’s Board of Directors.
Click to Tweet

San Diego, CA – May 19, 2015 - Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory announced today that the sixteenth Chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s Board of Directors.

SAN DIEGO, CA / Washington DC – May 14, 2015 – Pathway Genomics Corporation, a data-driven global healthcare company and global clinical laboratory, today announced that Founder and CEO Jim Plante has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3).

SAN DIEGO, Apr 29, 2015 — Mandy Kenyon, MS, RD, CSSD, is Pathway Genomics’ Registered Dietitian and played a major role in developing the customized diet plans that are part of tests such as Pathway Fit. Mandy is available to answer nutrition- and diet-related questions for Pathway’s clients and customers—contact her at rd@pathway.com.

Mandy recently shared a couple of the most common questions she receives in her work as a dietitian, as well as her responses:

Q: I have a healthy diet, no history of heart disease in my family, and I am overweight but not obese—do I really need to exercise?A: Absolutely. Being overweight (a BMI of 25.0–29.9) can have consequences, such as an increased risk of coronary heart disease, high blood pressure, stroke, and type II diabetes. Exercise can reduce these risks, and may improve both your current and future health by lessening the chance of complications later on.

No. In fact, everyone has genetic changes – it’s why we’re all different. Some genetic changes, called pathogenic variants, can be harmful to an individual, and in some cases, to their children if passed down.

Many other genetic changes; however, are quite common and have no known effect on health – we call these benign variants, and they’re just part of natural human variation. Some genetic changes can even be beneficial, such as those associated with reduced risk for certain diseases like Alzheimer disease.
Can I fix a pathogenic variant in my genes?
This is a very common question, and right now the answer is no. Your genes are in almost every cell in your body, and there’s just no way to go in and fix an alteration in the genetic code in each and every cell. However, research is ongoing and may make this a possibility in the future.

San Diego, CA – March 11, 2015 – Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, has announced that endocrinologist Dr. Glenn D. Braunstein is the company’s new Chief Medical Officer. Dr. Braunstein takes on the role after serving on Pathway Genomics’ Strategic Advisory Board. With a special interest in pharmacogenomics, Dr. Braunstein’s first priority will be Pathway Genomics’ pharmacogenomic testing menu.